Patient number | Other treatments to cure LL except for conservative therapy before TL | Diagnosis | Surgery | LL location | Daily chyle/lymph output (mL/day) | Time interval between surgery and TL (days) | Volume of iodinated oil injected in TL (mL) | Interval between TL and ALVS (days) | Volume of 95% ethanol injected in ALVS (mL) | Clinical outcomes of ALVS | Salvage treatment after clinically failed ALVS | Interval between ALVS and the cure of LL (days) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | None | Esophagus carcinoma | Thoracic-abdominal esophagus resection + lymphadenectomy | Chylothorax | 1,100 | 22 | 16.0 | 8 | 4.0 | Clinical failure | Yes: surgical revision | 13 |
2 | None | Erosive esophagitis induced esophageal stenosis | Thoracic-abdominal esophagus resection + lymphadenectomy | Chylothorax | 1,130 | 15 | 15.0 | 3 | 4.0 | Clinical success | No | 8 |
3 | None | Thoracic aortic aneurysm (dislocation of the grafts) | Descending aorta replacement | Chylothorax | 1,500 | 14 | 15.0 | 8 | 2.0 | Clinical success | No | 7 |
4 | Surgical revision | Cutaneous Merkel cell carcinoma | Inguinal lymphadenectomy | Inguinal lymphatic fistula | 200 | 28 | 9.0 | 5 | 5.0 | Clinical success | No | 8 |
5 | Surgical revision | Penile carcinoma | Inguinal lymphadenectomy | Inguinal lymphatic fistula | 340 | 24 | 20.0 | 13 | 2.0 | Clinical success | No | 7 |
6 | Surgical revision | Malignant melanoma | Inguinal lymphadenectomy | Inguinal lymphatic fistula | 100 | 70 | 5.0 | 10 | 1.0 | Clinical success | No | 1 |
7 | None | Chondrosarcoma | Bone tumour resection | Lymphatic fistula at the thigh | 300 | 13 | 6.0 | 11 | 2.0 | Clinical success | No | 20 |
8 | Doxycycline instillation (100 mg/3 times) | Malignant melanoma | Inguinal lymphadenectomy | Lymphatic fistula at the thigh | 100 | 18 | 10.0 | 18 | 2.0 | Clinical success | No | 3 |
9 | None | Malignant melanoma | Inguinal lymphadenectomy | Lymphatic fistula at the thigh | 100 | 36 | 10.0 | 28 | 2.0 | Clinical success | No | 1 |